You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)擬參與設立南京星健睿贏股權投資合夥企業
格隆匯 12-28 17:20

格隆匯12月28日丨復星醫藥(02196.HK)公佈,於2020年12月28日,公司董事會會議審議通過關於參與出資設立南京星健睿贏股權投資合夥企業(有限合夥)的議案。同意控股子公司/企業南京復鑫股權投資管理合夥企業(有限合夥)、寧波復瀛投資有限公司與包括關聯/連方上海復星高科技(集團)有限公司在內的其他4方投資人共同出資參與設立南京星健睿贏股權投資合夥企業(有限合夥),其中:南京復鑫作為普通合夥人、寧波復瀛作為有限合夥人分別現金出資人民幣1,010萬元、32,000萬元認繳目標基金中的等值財產份額;並同意聘任上海復健股權投資基金管理有限公司擔任目標基金的基金管理人。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account